tiprankstipranks
Citius Oncology (CTOR)
NASDAQ:CTOR
US Market
CTOR
Citius Oncology
RESEARCH TOOLSreports
Want to see CTOR full AI Analyst Report?

Citius Oncology (CTOR) Ratios

133 Followers

Citius Oncology Ratios

CTOR's free cash flow for Q3 2026 was $-0.48. For the 2026 fiscal year, CTOR's free cash flow was decreased by $ and operating cash flow was $-5.84. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 0.73 0.56 0.34 0.37
Quick Ratio
 0.34 0.11 0.08 0.37
Cash Ratio
 0.28 0.08 <0.01 <0.01
Solvency Ratio
 -0.61 -0.44 -0.55 -0.57
Operating Cash Flow Ratio
 -0.34 -0.11 <0.01 -0.03
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -29.00M$ -28.53M$ -27.26M$ -14.46M
Leverage Ratios
Debt-to-Assets Ratio
 0.09 0.04 0.05 0.00
Debt-to-Equity Ratio
 0.25 0.08 0.08 0.00
Debt-to-Capital Ratio
 0.20 0.08 0.08 0.00
Long-Term Debt-to-Capital Ratio
 0.20 0.08 0.08 0.00
Financial Leverage Ratio
 2.78 2.25 1.83 1.87
Debt Service Coverage Ratio
 -79.14 -112.57 0.00 0.00
Interest Coverage Ratio
 -86.40 -107.89 0.00 0.00
Debt to Market Cap
 0.12 0.03 0.04 0.00
Interest Debt Per Share
 0.10 0.05 0.05 0.00
Net Debt to EBITDA
 0.15 <0.01 -0.18 <0.01
Profitability Margins
Gross Profit Margin
53.13%0.00%0.00%0.00%
EBIT Margin
-639.30%0.00%0.00%0.00%
EBITDA Margin
-607.02%0.00%0.00%0.00%
Operating Profit Margin
-665.63%0.00%0.00%0.00%
Pretax Profit Margin
-645.64%0.00%0.00%0.00%
Net Profit Margin
-648.32%0.00%0.00%0.00%
Continuous Operations Profit Margin
-648.32%0.00%0.00%0.00%
Net Income Per EBT
100.41%104.46%102.80%104.75%
EBT Per EBIT
97.00%100.77%100.00%100.00%
Return on Assets (ROA)
-41.09%-24.53%-25.07%-26.60%
Return on Equity (ROE)
-102.98%-55.19%-45.84%-49.72%
Return on Capital Employed (ROCE)
-88.72%-45.72%-39.82%-45.42%
Return on Invested Capital (ROIC)
-88.72%-45.72%-39.82%-45.42%
Return on Tangible Assets
-107.86%-24.53%-25.07%-164.16%
Earnings Yield
-45.42%-16.65%-21.26%-1.24%
Efficiency Ratios
Receivables Turnover
 10.35 0.00 0.00 0.00
Payables Turnover
 0.46 0.00 0.00 0.00
Inventory Turnover
 0.15 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00
Asset Turnover
 0.06 0.00 0.00 0.00
Working Capital Turnover Ratio
 -0.31 0.00 0.00 0.00
Cash Conversion Cycle
 1.71K 0.00 0.00 0.00
Days of Sales Outstanding
 35.25 0.00 0.00 0.00
Days of Inventory Outstanding
 2.48K 0.00 0.00 0.00
Days of Payables Outstanding
 801.79 0.00 0.00 0.00
Operating Cycle
 2.52K 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.18 -0.07 <0.01 >-0.01
Free Cash Flow Per Share
 -0.18 -0.07 <0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -1.41M -1.37M 31.59K -150.33K
Capital Expenditure Coverage Ratio
 -1.41M -1.37M 31.59K -150.33K
Operating Cash Flow Coverage Ratio
 -1.93 -1.45 0.03 0.00
Operating Cash Flow to Sales Ratio
 -2.77 0.00 0.00 0.00
Free Cash Flow Yield
-22.55%-3.69%0.13%-0.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.97 -5.97 -4.70 -80.55
Price-to-Sales (P/S) Ratio
 12.30 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 2.51 3.32 2.16 40.05
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.44 -27.08 787.17 -1.70K
Price-to-Operating Cash Flow Ratio
 -5.15 -27.08 787.14 -1.70K
Price-to-Earnings Growth (PEG) Ratio
 0.05 -0.45 -0.08 -0.54
Price-to-Fair Value
 2.51 3.32 2.16 40.05
Enterprise Value Multiple
 -1.88 -6.33 -5.02 -84.37
Enterprise Value
 81.05M 148.61M 103.26M 1.02B
EV to EBITDA
 -1.88 -6.33 -5.02 -84.37
EV to Sales
 11.41 0.00 0.00 0.00
EV to Free Cash Flow
 -4.11 -27.06 817.24 -1.70K
EV to Operating Cash Flow
 -4.11 -27.06 817.22 -1.70K
Tangible Book Value Per Share
 -0.27 0.61 0.64 -0.16
Shareholders’ Equity Per Share
 0.37 0.61 0.64 0.29
Tax and Other Ratios
Effective Tax Rate
 >-0.01 -0.04 -0.03 -0.05
Revenue Per Share
 0.07 0.00 0.00 0.00
Net Income Per Share
 -0.43 -0.34 -0.30 -0.14
Tax Burden
 1.00 1.04 1.03 1.05
Interest Burden
 1.01 1.01 1.00 1.00
Research & Development to Revenue
 0.48 0.00 0.00 0.00
SG&A to Revenue
 6.39 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00
Income Quality
 0.43 0.22 >-0.01 0.05
Currency in USD